1. GSK allies with Innovax for COVID-19 vaccine R&D project— Zentalis Pharma raises $165M in IPO — Drug discovery in the age of coronavirus — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

CVS Caremark Corp. Earnings infoGraphic: Q2 2017

Discussion in 'Pharma/Biotech Companies - Compliance' started by RobertPhillips900, Aug 9, 2017 at 4:18 PM.

  1. RobertPhillips900

    Joined:
    Aug 29, 2016
    Messages:
    51
    Likes Received:
    0
    $CVS reported 19% growth in its 2Q17 profit, due to absence of $542MM loss on the early retirement of debt. Net earnings rose to $1.1Bil, or $1.07 per share, compared to $924MM, or $0.86 per share, during 2Q16. Net revenue rose 5% to $45.6Bil. Excluding items, $CVSearned $1.33 per share

    CVS Caremark Corp. Earnings InfoGraphic: Q2 2017 highlights http://alph.st/b918ae35